ULTRACEMCO - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 3.4
| Stock Code | ULTRACEMCO | Market Cap | 3,18,677 Cr. | Current Price | 10,814 ₹ | High / Low | 13,110 ₹ |
| Stock P/E | 42.2 | Book Value | 2,401 ₹ | Dividend Yield | 0.72 % | ROCE | 11.7 % |
| ROE | 9.69 % | Face Value | 10.0 ₹ | DMA 50 | 12,075 ₹ | DMA 200 | 12,002 ₹ |
| Chg in FII Hold | -0.89 % | Chg in DII Hold | 0.80 % | PAT Qtr | 1,570 Cr. | PAT Prev Qtr | 1,064 Cr. |
| RSI | 32.7 | MACD | -451 | Volume | 2,91,071 | Avg Vol 1Wk | 4,84,715 |
| Low price | 10,573 ₹ | High price | 13,110 ₹ | PEG Ratio | -12.7 | Debt to equity | 0.30 |
| 52w Index | 9.50 % | Qtr Profit Var | 18.6 % | EPS | 254 ₹ | Industry PE | 27.0 |
📊 ULTRACEMCO shows moderate fundamentals for long-term investment. While it has strong market leadership and consistent profitability (EPS 254 ₹, PAT 1,570 Cr. vs 1,064 Cr., +18.6%), efficiency metrics are weak with ROE (9.69%) and ROCE (11.7%) below desirable levels. Valuations are stretched with a P/E of 42.2 compared to the industry average (27.0), and the PEG ratio (-12.7) highlights poor growth prospects. Dividend yield (0.72%) is modest. Technical indicators (RSI 32.7, MACD -451) show bearish momentum, with the stock trading below both 50 DMA (12,075 ₹) and 200 DMA (12,002 ₹).
💰 Ideal Entry Price Zone: Investors can consider accumulating between 10,600–10,800 ₹, near current support levels. A deeper value entry would be closer to 10,200–10,400 ₹ if weakness persists.
📈 Exit Strategy / Holding Period: For existing holders, ULTRACEMCO is a fair candidate for medium-to-long-term holding (3–5 years) given its market leadership and profitability. Partial profit booking can be considered near 12,000–12,200 ₹ (DMA zone). Long-term holding is less attractive unless ROE and ROCE improve significantly.
✅ Positive
- Strong EPS (254 ₹) supports profitability.
- Quarterly PAT growth (+18.6%) shows earnings momentum.
- DII holdings increased (+0.80%), reflecting domestic institutional support.
- Debt-to-equity ratio low at 0.30, ensuring financial stability.
⚠️ Limitation
- Weak ROE (9.69%) and ROCE (11.7%).
- High P/E (42.2) compared to industry PE (27.0).
- PEG ratio negative (-12.7), indicating poor growth prospects.
- Dividend yield modest at 0.72%.
📉 Company Negative News
- Technical weakness: RSI oversold (32.7), MACD negative (-451).
- FII holdings decreased (-0.89%), showing reduced foreign investor confidence.
📈 Company Positive News
- Quarterly PAT improved (1,570 Cr. vs 1,064 Cr.).
- DII holdings increased, reflecting domestic institutional support.
- Strong EPS highlights profitability despite weak efficiency metrics.
🏭 Industry
- Industry PE is 27.0, lower than ULTRACEMCO’s valuation, highlighting premium pricing.
- Cement sector benefits from infrastructure growth and housing demand in India.
🔎 Conclusion
ULTRACEMCO is a moderately strong company with consistent profitability and market leadership, but weak efficiency metrics and stretched valuations limit its appeal. Ideal entry is near 10,600–10,800 ₹, with a medium-term holding horizon of 3–5 years. Existing investors should continue holding cautiously, with partial profit booking near 12,000–12,200 ₹ if valuations stretch. Long-term holding is less attractive unless ROE and ROCE improve significantly.